BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19166978)

  • 1. Skin lesions in a patient on therapy for chronic hepatitis C.
    Hisamuddin K; Veluru C; Mullen KD
    Clin Gastroenterol Hepatol; 2009 Jun; 7(6):A24. PubMed ID: 19166978
    [No Abstract]   [Full Text] [Related]  

  • 2. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
    Jessner W; Der-Petrossian M; Christiansen L; Maier H; Steindl-Munda P; Gangl A; Ferenci P
    Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
    [No Abstract]   [Full Text] [Related]  

  • 3. Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy.
    Berk DR; Mallory SB; Keeffe EB; Ahmed A
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):142-51. PubMed ID: 16919505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic hepatitis with boceprevir leads to remission of porphyria cutanea tarda.
    Aguilera P; Laguno M; To-Figueras J
    Br J Dermatol; 2014 Dec; 171(6):1595-6. PubMed ID: 25154788
    [No Abstract]   [Full Text] [Related]  

  • 5. Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy.
    Bruzzone B; Magnani O; Sticchi L; Canepa P; Rappazzo E; Icardi G; Setti M
    J Antimicrob Chemother; 2017 Oct; 72(10):2955-2958. PubMed ID: 29091216
    [No Abstract]   [Full Text] [Related]  

  • 6. Improvement of porphyria cutanea tarda following treatment of hepatitis C virus by direct-acting antivirals: A case report.
    Nihei T; Kiniwa Y; Mikoshiba Y; Joshita S; Okuyama R
    J Dermatol; 2019 May; 46(5):e149-e151. PubMed ID: 30506825
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe pruritus after completing pegylated interferon for hepatitis C.
    Hoffman CJ; Ray SC
    AIDS Read; 2008 Nov; 18(11):562-5. PubMed ID: 19062400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegylated interferon-induced eyelid and eyebrow trichomegaly during chronic hepatitis C.
    Howaizi M
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1945-6. PubMed ID: 16336462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis C with extrahepatic manifestations.
    Poantă L; Albu A
    Rom J Intern Med; 2007; 45(1):85-8. PubMed ID: 17966447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Images in clinical medicine: Porphyria cutanea tarda.
    Chan CC; Lin SJ
    N Engl J Med; 2011 Sep; 365(12):1128. PubMed ID: 21992125
    [No Abstract]   [Full Text] [Related]  

  • 11. A blistering rash.
    Adejumo AA; Mannheimer SB
    Am J Med; 2010 Apr; 123(4):317-9. PubMed ID: 20362750
    [No Abstract]   [Full Text] [Related]  

  • 12. Lesions on the hands, high aminotransferase levels.
    Gil-Mosquera M; Vañó-Galván S; Gomez-Guerra R; Jaén P; Gil-Mosquera M
    Cleve Clin J Med; 2010 Jan; 77(1):34-6. PubMed ID: 20048027
    [No Abstract]   [Full Text] [Related]  

  • 13. Resolution of Porphyria Cutanea Tarda in Patients With Hepatitis C Following Ledipasvir-Sofosbuvir Combination Therapy.
    Tong Y; Song YK; Tyring S
    JAMA Dermatol; 2016 Dec; 152(12):1393-1395. PubMed ID: 27732687
    [No Abstract]   [Full Text] [Related]  

  • 14. [Porphyria cutanea tarda as extrahepatic manifestation of chronic hepatitis C: a case report].
    Espinoza-Ríos J; Valenzuela Granados V; Ojeda Cisneros M; Gálvez Canseco A; Ramos Aguilar C; Raymundo Villalva B; Aguilar Sánchez V; Pinto Valdivia J; Huerta-Mercado Tenorio J; Bussalleu Rivera A
    Rev Gastroenterol Peru; 2017; 37(4):394-398. PubMed ID: 29459814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Porphyria cutanea tarda, hemodialysis and HCV hepatopathy].
    Muray S; Casanova JM; Marco MP; Craver L; Martín M; Fernández E
    Nefrologia; 2002; 22(6):570-3. PubMed ID: 12516291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda.
    Yachimski P; Shah N; Chung RT
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):e6. PubMed ID: 17296523
    [No Abstract]   [Full Text] [Related]  

  • 17. Can curative antivirals benefit porphyria cutanea tarda in hepatitis C patients?
    Hatch MM; Nawas Z; Kollipara R; Tyring SK
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):e194. PubMed ID: 27550066
    [No Abstract]   [Full Text] [Related]  

  • 18. Pustular Skin Lesions.
    Awad MT; Banifadel M
    Gastroenterology; 2021 Feb; 160(3):675-676. PubMed ID: 32569774
    [No Abstract]   [Full Text] [Related]  

  • 19. Porphyria cutanea tarda induced by olmesartan.
    Mas-Vidal A; Coto-Segura P; García-Varona A; Santos-Juanes J
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):977-8. PubMed ID: 20015057
    [No Abstract]   [Full Text] [Related]  

  • 20. Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C.
    Sheikh MY; Wright RA; Burruss JB
    Dig Dis Sci; 1998 Mar; 43(3):529-33. PubMed ID: 9539647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.